Acute Upper Airway Disease in Children With the Omicron (B.1.1.529) Variant of SARS-CoV-2—A Report From the US National COVID Cohort Collaborative-Reference-Cited by-同舟云学术

Acute Upper Airway Disease in Children With the Omicron (B.1.1.529) Variant of SARS-CoV-2—A Report From the US National COVID Cohort Collaborative

Published:2022-08-01 Issue:8 Volume:176 Page:819
ISSN:2168-6203
Container-title:JAMA Pediatrics
language:en
Short-container-title:JAMA Pediatr

Author:

Martin Blake¹,DeWitt Peter E.²,Russell Seth²,Sanchez-Pinto L. Nelson³,Haendel Melissa A.⁴,Moffitt Richard⁵,Bennett Tellen D.²

Affiliation:

1. Section of Critical Care Medicine, Department of Pediatrics, University of Colorado School of Medicine, Aurora

2. Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, Aurora

3. Division of Critical Care, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois

4. Department of Biochemistry and Molecular Genetics and the Center for Health Artificial Intelligence, University of Colorado School of Medicine, Aurora

5. Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York

Abstract

This cohort study uses data from the US National COVID Cohort Collaborative to evaluate upper airway infections in children during the surge of the Omicron (B.1.1.529) variant of SARS-CoV-2 in the US.

Publisher

American Medical Association (AMA)

Subject

Pediatrics, Perinatology and Child Health

Link

https://jamanetwork.com/journals/jamapediatrics/articlepdf/2791278/jamapediatrics_martin_2022_ld_220016_1667510924.68411.pdf

Reference6 articles.

1. Characteristics, outcomes, and severity risk factors associated with SARS-CoV-2 infection among children in the US national COVID cohort collaborative.;Martin;JAMA Netw Open,2022

2. Pediatric croup with COVID-19.;Venn;Am J Emerg Med,2021

3. The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment.;Haendel;J Am Med Inform Assoc,2021

4. Centers for Disease Control and Prevention. COVID Data Tracker: Variant Proportions. Accessed January 19, 2022. https://covid.cdc.gov/covid-data-tracker/#variant-proportions

5. Chan? MC, Hui? KP, Ho? J, . SARS-CoV-2 Omicron variant replication in human respiratory tract ex vivo.? Research Square. Preprint posted online December 22, 2021. doi:10.21203/rs.3.rs-1189219/v1

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and hematological characteristics of children infected with the omicron variant of SARS-CoV-2: role of the combination of the neutrophil: lymphocyte ratio and eosinophil count in distinguishing severe COVID-19;Frontiers in Pediatrics;2024-06-24

2. Clinical spectrum of disease and outcomes in children with Omicron SARS-COV-2 infection in Cape Town, South Africa;IJTLD OPEN;2024-01-01

3. Differences in the Clinical Manifestations and Host Immune Responses to SARS-CoV-2 Variants in Children Compared to Adults;Journal of Clinical Medicine;2023-12-26

4. Clinical and laboratory aspects of the new coronavirus infection in newborns and infants;CHILDREN INFECTIONS;2023-11-17

5. Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-C;Frontiers in Pediatrics;2023-10-18